Brief: Lucid Diagnostics' Esoguard BE-1 Prospective Multicenter Clinical Validation Study Of Esoguard Esophageal Precancer Testing Accepted For Peer-Reviewed Publication

Lucid Diagnostics

07/11/2024 13:10

Nov 7 (Reuters) - Lucid Group Inc  LCID.O :
    * LUCID DIAGNOSTICS' ESOGUARD BE-1 PROSPECTIVE MULTICENTER
CLINICAL VALIDATION STUDY OF ESOGUARD® ESOPHAGEAL PRECANCER
TESTING ACCEPTED FOR PEER-REVIEWED PUBLICATION

Source text:  ID:nPntpx6Ra 
Further company coverage:  LCID.O 

 (Reuters.Briefs@thomsonreuters.com)